Advertisement
News
Subscribe to MDT Magazine News

Brain can learn to overcome sleep apnea: U of T scientist

February 1, 2011 12:36 pm | by EurekAlert | Comments

(University of Toronto) New research from the University of Toronto could provide some restful nights for the 18 million North Americans who suffer from obstructive sleep apnea.

TOPICS:

New clinical trial to determine ovarian cancer risks in African-American women

February 1, 2011 12:35 pm | by EurekAlert | Comments

(University Hospitals Case Medical Center) University Hospitals Case Medical Center and Case Western Reserve University School of Medicine are conducting a new study addressing lack of knowledge about causes and risk factors for ovarian cancer in African-American women. Ovarian cancer is...

TOPICS:

Reportlinker Adds Bevacizumab - Comprehensive Patent Search

February 1, 2011 12:35 pm | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 1, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Bevacizumab - Comprehensive patent search http://www.reportlinker.com/p0366187/Bevacizumab---Comprehensive-patent-search.html Eliminate unnecessary risk with the industry...

TOPICS:
Advertisement

Reportlinker Adds Dry Powder Inhalation

February 1, 2011 12:35 pm | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 1, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Dry Powder Inhalation http://www.reportlinker.com/p0369401/Dry-Powder-Inhalation.html The convergence of socioeconomic and technology factors – the growing emphasis...

TOPICS:

Reportlinker Adds Delivering Drugs by Inhalation

February 1, 2011 12:35 pm | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 1, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Delivering Drugs by Inhalation http://www.reportlinker.com/p0369398/Delivering-Drugs-by-Inhalation.html Advances in drug formulation and inhalation device design are...

TOPICS:

Featured Search — PET/MRI Not Recommended As Alternative to Magnetic Resonance Mammography

February 1, 2011 12:34 pm | by Diagnostic Imaging | Comments

German radiologists find that PET/MRM is no better than magnetic resonance mammography alone at evaluating local breast tumors.

TOPICS:

For-profits may be cherry-picking hospice patients

February 1, 2011 11:45 am | by LINDSEY TANNER - AP Medical Writer - Associated Press | Comments

For-profit hospices may be cherry-picking the least costly, most lucrative patients, potentially putting the nonprofit industry at a financial disadvantage, a study suggests.The researchers found hospice care provided by for-profit agencies averaged 20 days versus 16 days for nonprofit...

Kinetic Concepts 4Q profit grows 12 percent

February 1, 2011 11:45 am | by The Associated Press | Comments

Medical technology company Kinetic Concepts Inc. said Tuesday its profit rose 12 percent in the fourth quarter on lower tax and interest costs.Kinetic Concepts said its profit grew to $74 million, or $1.03 per share, from $66.3 million, or 93 cents per share, one year ago. Excluding one-time...

Advertisement

Kensey Nash 2Q profit down 9 percent as sales fall

February 1, 2011 10:45 am | by The Associated Press | Comments

Medical device company Kensey Nash Corp. said Tuesday its profit fell 9 percent in the fiscal second quarter as high unemployment and a difficult market for health insurance hurt its sales.Kensey Nash said its profit fell to $3.3 million in the three-month period that ended Dec. 31, from $3.7...

Maturitas publishes important position statements from European Menopause and Andropause Society

February 1, 2011 10:35 am | by EurekAlert | Comments

(Elsevier) Elsevier announced today the publication of two further important position statements from the European Menopause and Andropause Society in the journal Maturitas on common management problems in the post-reproductive health of women.

TOPICS:

Researchers test inhalable measles vaccine

February 1, 2011 10:35 am | by EurekAlert | Comments

(Johns Hopkins University Bloomberg School of Public Health) Sustained high vaccination coverage is key to preventing deaths from measles. Despite the availability of a vaccine, measles remains an important killer of children worldwide, particularly in less-developed regions where...

TOPICS:

Reportlinker Adds Pen Injectors

February 1, 2011 10:34 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 1, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Pen Injectors http://www.reportlinker.com/p0369406/Pen-Injectors.html User-friendly designs and the availability of an increasing number of drugs in pre-filled disposable...

TOPICS:

Inflammation Identified as New Therapeutic Target Years After Stroke

February 1, 2011 10:33 am | by Bio-Medicine.Org | Comments

LOS ANGELES, Feb. 1, 2011 /- A breakthrough in stroke research identifying the potential reversibility of chronic neurologic disability in stroke survivors has published today. In the February 1, 2011 issue of the journal CNS Drugs the first human results of a new method of targeting...

TOPICS:

PTC Therapeutics and Parent Project Muscular Dystrophy Advance Drug Discovery Program to Improve Heart Function in Duchenne/Becker Muscular Dystrophy Patients

February 1, 2011 10:33 am | by Bio-Medicine.Org | Comments

SOUTH PLAINFIELD, N.J. and HACKENSACK, N.J., Feb. 1, 2011 /- PTC Therapeutics, Inc. (PTC) and Parent Project Muscular Dystrophy (PPMD) today announced an expansion of their collaboration to discover new treatments for patients with Duchenne/Becker muscular dystrophy (DBMD).  PPMD has...

TOPICS:

Ongoing Negotiation on Top Brand Health Device Cooperation

February 1, 2011 10:32 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, Feb. 1, 2011 /PRNewswire-Asia/ -- Shenzhen Wuzhou Changlian International Trading Co., a rapidly growing international trading company in China, unveiled its currently  ongoing business negotiations  and possible prospective business partners today, as the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading